STM publisher Elsevier, Netherlands, has announced that its journal Biomaterials will introduce two new initiatives in 2011.
The first concerns the change in subject sections included in the journal. This represents the rapidly moving subject area, which is increasingly interdisciplinary and splintering into new and emerging sub fields. One of these new sections may be highlighted as particularly timely given recent scientific developments in advanced, materials-based cancer technologies: Biomaterials and Cancer.
The journal is now accepting papers on cancer, chemotherapy, immunotherapy, imaging and diagnostics, theranostics, cancer modelling, carcinogenicity and other biomaterials related aspects of cancer.
Separate and additional to these sections, is the introduction of an entirely new format to present scientific opinion. This change is in response to the many areas within biomaterials science where all the facts are not yet known, but where informed opinions could be valuable in shaping the future. The journal will have the occasional 'Debate Section.' Leading opinion papers will be highlighted and linked together in debate format. The aim of these contributions is to inform and engage the scientific community around important topics.
The first issue of Biomaterials featuring the Debate Section can be located at http://www.sciencedirect.com/science/issue/5558-2011-999679981-3131736
Search for more STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
